Review articleGenetic tools for identifying and manipulating fibroblasts in the mouse
Section snippets
Fibrosis
Fibrosis, the deposition of extracellular matrix in response to injury, inflammation, and aging, can be either reparative or reactive. The organs that commonly exhibit fibrosis include the heart, kidney, liver, and lung (Zeisberg and Kalluri, 2013, Rockey et al., 2015). Despite the fact that a chronic fibrogenic response ultimately leads to organ dysfunction and failure, accounting for an estimated one third of natural deaths worldwide (Zeisberg and Kalluri, 2013), few therapeutic options have
Fibroblast definition
One of the key issues to understanding fibrosis is delineation of the role of the fibroblast. This endeavor is complicated, as the fibroblast is poorly defined and sometimes considered immature in regards to its differentiation status (Alberts et al., 2002). Anatomically, a fibroblast is described as a connective tissue cell that produces extracellular matrix (Alberts et al., 2002). Within this definition there are two main classifications: the adventitial fibroblast that surrounds blood
Cardiac fibroblasts
Similar to fibroblasts in other organs, cardiac fibroblasts are a poorly-defined cell population (Snider et al., 2009). Commonly, vimentin, collagen production, CD90, and DDR2 expression have been used to define the quiescent cardiac fibroblast population, while αSMA expression defines the activated fibroblast (Travers et al., 2016). Because many of these markers are expressed by other cell types, it has been difficult to generate a genetic tagging system that is specific to cardiac
Concluding remarks
It is clear from existing data that tools for effectively identifying and manipulating tissue resident cells with fibrogenic potential are in their infancy. The lack of a consensus regarding phenotypic markers for these cells under non-pathological conditions stems from the fact that clear designations for these cell types have not been determined. Recent data has refined our ideas relating to the cell types involved and have reinforced the notion that fibrogenic cells in each organ have unique
Funding sources
This work was supported by National Heart, Lung, and Blood Institute grants [HL074257, HL100401 to M.D.T.]; [F31HL126512 to M.J.I]; [F31HL128048 to J.M.S.]; and an Institutional Cardiology Training Grant position [T32 HL115505 to J.M.S.].
References (225)
- et al.
Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning
Cell
(2004) - et al.
Pericytes: developmental, physiological, and pathological perspectives, problems, and promises
Dev. cell
(2011) - et al.
beta-catenin regulates mesenchymal progenitor cell differentiation during hepatogenesis
J. Surg. Res.
(2010) - et al.
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway
Cancer cell
(2012) - et al.
Origin of new cells in the adult kidney: results from genetic labeling techniques
Kidney Int.
(2011) - et al.
Mapping cell fate and function using recombinase-based intersectional strategies
Methods Enzym.
(2010) - et al.
Hedgehog-Gli pathway activation during kidney fibrosis
Am. J. Pathol.
(2012) - et al.
Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly
Cell
(2006) - et al.
Mesenchymal-specific deletion of C/EBPbeta suppresses pulmonary fibrosis
Am. J. Pathol.
(2012) - et al.
Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis
Am. J. Pathol.
(2015)